1 minute reading time (248 words)

Join us for ODACon™ 2022 Supportive Care Summit in November!

Oncology Data Advisor™ invites you to attend this one-day virtual conference focusing on breast cancer. This virtual conference will provide expert perspectives on the mechanisms of action and efficacy/safety profiles of novel therapy classes, therapeutic selection based on individual patient and tumor characteristics, and approaches for anticipating and detecting symptoms and side effects.

During 7 case-based interactive sessions, attendees will be able to apply emerging data and strategies for managing and supporting patients with breast cancer receiving novel breast cancer therapies, including the following:
  • Antibody-drug conjugates
  • CDK4/6 inhibitors
  • HER2 tyrosine kinase inhibitors
  • Immune checkpoint inhibitors
  • Monoclonal antibodies
  • PARP inhibitors
  • PI3K inhibitors

The conference will begin at 10:00 am EST / 7:00 am PST on Saturday, November 12, 2022.

Conference attendees will receive 5.5 CME/NCPD/ILNA credits.


i3 Health is pleased to partner with the National Breast Cancer Foundation for ODACon 2022.  

About National Breast Cancer Foundation, Inc.®

Recognized as one of the leading breast cancer organizations in the world, National Breast Cancer Foundation (NBCF) is Helping Women Now® by providing early detection, education, and support services to those affected by breast cancer. A recipient of Charity Navigator's highest 4-star rating for 16 years, NBCF provides support through their National Mammography Program, Patient Navigation, breast health education, and patient support programs. For more information, please visit https://www.nationalbreastcancer.org.

Copyright © 2022 Oncology Data Advisor. All rights reserved.